Weiyue Lu Selected Research

poly(gamma-glutamylglutamine)paclitaxel

11/2017	Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
4/2017	Co-administration of tLyp-1 with polymeric paclitaxel conjugates: Enhanced intratumoral accumulation and anti-tumor efficacy.
1/2017	A Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiyue Lu Research Topics

Disease

80	Neoplasms (Cancer) 04/2022 - 02/2008
41	Glioma (Gliomas) 01/2022 - 09/2012
25	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 04/2010
22	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2011
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2010
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
4	Fibrosis (Cirrhosis) 09/2020 - 09/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 10/2017
3	Hemolysis 07/2019 - 10/2008
3	Laryngeal Neoplasms (Laryngeal Cancer) 07/2015 - 10/2009
3	Lymphatic Metastasis 06/2015 - 01/2010
2	Triple Negative Breast Neoplasms 01/2022 - 01/2017
2	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 11/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2021 - 08/2021
2	Lung Neoplasms (Lung Cancer) 10/2020 - 01/2017
2	Adenocarcinoma 10/2020 - 08/2015
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 10/2019
2	Melanoma (Melanoma, Malignant) 04/2019 - 01/2016
2	Necrosis 01/2019 - 02/2008
2	Bacterial Infections (Bacterial Infection) 09/2017 - 03/2016
2	Infections 03/2016 - 06/2015

Drug/Important Bio-Agent (IBA)

48	Peptides (Polypeptides)IBA 01/2022 - 01/2010
45	Pharmaceutical PreparationsIBA 04/2022 - 10/2008
33	LigandsIBA 04/2022 - 10/2011
30	Liposomes (Liposome)IBA 01/2022 - 02/2008
21	MicellesIBA 01/2020 - 05/2009
20	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 10/2009
18	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 02/2008
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
10	IntegrinsIBA 01/2021 - 09/2011
9	Neuropilin-1IBA 09/2018 - 10/2013
8	cyclic arginine-glycine-aspartic acid peptideIBA 01/2020 - 04/2010
8	PolyethyleneimineIBA 08/2015 - 08/2011
7	PolymersIBA 10/2020 - 01/2005
7	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 08/2015 - 08/2011
6	monomethoxypolyethylene glycol (MPEG)IBA 07/2015 - 05/2009
5	polypeptide CIBA 01/2021 - 04/2010
5	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 01/2020 - 04/2010
5	Nanoparticle Drug Delivery SystemIBA 03/2018 - 06/2012
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 06/2016
5	Ethylene Glycol (Monoethylene Glycol)IBA 06/2015 - 04/2010
4	Endoplasmic Reticulum Chaperone BiPIBA 01/2022 - 10/2017
4	Therapeutic UsesIBA 01/2022 - 10/2013
4	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2018
4	Gemcitabine FDA Link 12/2021 - 01/2015
4	LipidsIBA 01/2020 - 04/2016
4	polyethylene glycol- distearoylphosphatidylethanolamineIBA 10/2017 - 05/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2011
3	Cell-Penetrating PeptidesIBA 01/2022 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 09/2011
3	Biological ProductsIBA 12/2021 - 02/2014
3	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 11/2015
3	AntibodiesIBA 01/2021 - 12/2016
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2020 - 05/2009
3	Cholinergic ReceptorsIBA 11/2020 - 11/2015
3	Nicotine FDA Link 11/2020 - 11/2015
3	poly(gamma-glutamylglutamine)paclitaxelIBA 11/2017 - 01/2017
3	CarbonIBA 10/2017 - 12/2015
3	ErbB Receptors (EGF Receptor)IBA 07/2017 - 01/2015
2	cabazitaxel FDA Link 01/2022 - 01/2022
2	HydrogelsIBA 10/2021 - 06/2015
2	Docetaxel (Taxotere)FDA Link 10/2021 - 01/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 10/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 10/2019
2	Immune Checkpoint InhibitorsIBA 10/2020 - 04/2019
2	phenolic acidIBA 10/2020 - 09/2017
2	Antisense OligonucleotidesIBA 09/2020 - 08/2017
2	Drug CarriersIBA 01/2020 - 04/2016
2	Melitten (Melittin)IBA 07/2019 - 04/2016
2	GlycopeptidesIBA 07/2019 - 01/2018
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 10/2018 - 01/2018
2	Myristic Acid (Tetradecanoic Acid)IBA 06/2018 - 10/2011
2	Nucleic AcidsIBA 01/2018 - 01/2018
2	Staphylococcal Protein A (Protein A)IBA 01/2018 - 01/2017
2	Contrast MediaIBA 01/2018 - 01/2012
2	Gadolinium DTPA (Magnevist)FDA Link 01/2018 - 01/2017
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2018 - 01/2017
2	RGERPPR peptideIBA 01/2018 - 12/2013
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 01/2017
2	Monoclonal AntibodiesIBA 08/2017 - 02/2008
2	Fluorescein (Funduscein)FDA LinkGeneric 04/2016 - 01/2013
2	Tumor Suppressor Protein p53IBA 11/2015 - 04/2012
2	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 06/2015 - 05/2009
2	aspartic acid glycine arginineIBA 06/2012 - 04/2010
2	Tyrosine (L-Tyrosine)FDA Link 06/2012 - 04/2010
2	Lysine (L-Lysine)FDA Link 06/2012 - 04/2010
2	poly(lactide) (polylactic acid)IBA 06/2012 - 04/2010
2	Dendrimers (Dendrons)IBA 01/2012 - 07/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 05/2009
2	polyethylene glycol-poly(lactide-co-glycolide)IBA 10/2010 - 01/2010

Therapy/Procedure

38	Therapeutics 01/2022 - 01/2010
14	Drug Therapy (Chemotherapy) 04/2022 - 10/2009
7	Intravenous Administration 10/2020 - 04/2010
5	Precision Medicine 01/2018 - 01/2017
4	Intravenous Injections 01/2020 - 01/2016
2	Intravaginal Administration 10/2021 - 08/2021
2	Nanospheres 01/2017 - 12/2015
2	Radiotherapy 06/2014 - 10/2009